Kaye D[au] - Search Results

Year	Number of Results
1953	1
1961	3
1962	2
1963	9
1964	7
1965	3
1966	6
1967	12
1968	7
1969	7
1970	9
1971	3
1972	10
1973	15
1974	8
1975	5
1976	3
1977	7
1978	6
1979	4
1980	11
1981	7
1982	4
1983	5
1984	4
1985	9
1986	8
1987	11
1988	9
1989	9
1990	5
1991	7
1992	4
1993	8
1994	11
1995	23
1996	10
1997	7
1998	12
1999	11
2000	12
2001	26
2002	16
2003	25
2004	23
2005	14
2006	19
2007	18
2008	23
2009	22
2010	23
2011	35
2012	31
2013	31
2014	33
2015	28
2016	30
2017	37
2018	36
2019	45
2020	41
2021	50
2022	74
2023	71
2024	62
2025	62
2026	6

1

Echocardiographic Diastolic Function Grading in HFpEF: Testing the Updated 2025 ASE Criteria.

Harada T, Sorimachi H, Obokata M, Naser JA, Ibe T, Tada A, Doi S, Kazui S, Murakami T, Kagami K, Reddy YNV, Miranda WR, Manhaeghe L, Nanayakkara S, Janssen-Telders C, Handoko ML, Verbrugge FH, Kaye DM, Borlaug BA. Harada T, et al. Among authors: kaye dm. J Am Coll Cardiol. 2026 Jan 7:S0735-1097(25)10279-9. doi: 10.1016/j.jacc.2025.11.024. Online ahead of print. J Am Coll Cardiol. 2026. PMID: 41532943

2

A Pharmacokinetic Analysis of Intravenous Fluconazole in Adult Patients Undergoing Mechanical Circulatory Support Device Implantation.

Cairns KA, Hernandez-Mitre MP, Peel TN, Abbott IJ, Kaye DM, Marasco S, Daly D, Warner V, Coldham A, Pope JD, Schneider HG, Dooley MJ, Liu X, Roberts JA, Udy AA. Cairns KA, et al. Among authors: kaye dm. Clin Pharmacokinet. 2025 Dec 22. doi: 10.1007/s40262-025-01607-z. Online ahead of print. Clin Pharmacokinet. 2025. PMID: 41430005

3

Corrigendum to "Long-term safety and outcomes after atrial shunting for heart failure with preserved or mildly reduced ejection fraction: 5-year and 3-year follow-up in the REDUCE LAP-HF I and II trials" [American Heart Journal (278)2024 Page Number:106-116].

Litwin SE, Komtebedde J, Borlaug BA, Kaye DM, Hasenfuβ G, Kahwash R, Hoendermis E, Hummel SL, Cikes M, Gustafsson F, Chung ES, Mohan RC, Sverdlov AL, Swarup V, Winkler S, Hayward CS, Bergmann MW, Bugger H, McKenzie S, Nair A, Rieth A, Burkhoff D, Cutlip DE, Solomon SD, van Veldhuisen DJ, Leon MB, Shah SJ. Litwin SE, et al. Among authors: kaye dm. Am Heart J. 2026 Mar;293:107312. doi: 10.1016/j.ahj.2025.107312. Epub 2025 Dec 18. Am Heart J. 2026. PMID: 41418529 No abstract available.

4

Understanding the Causes of Nonadherence to Chronic Medications Among Patients With Cancer and Multimorbidity: A Qualitative Study.

Kaye DR, Varma R, Roud S, Fish L, Shenoy D, Parnell HE, Zullig LL, Ubel PA, Sloan CE. Kaye DR, et al. J Gen Intern Med. 2025 Dec 9. doi: 10.1007/s11606-025-09941-5. Online ahead of print. J Gen Intern Med. 2025. PMID: 41364401

5

Refining Atrial Shunt Therapy for HFpEF: Lessons from Pivotal Randomized Trials and Emerging Directions.

Gyberg DJ, Komtebedde J, Mylavarapu U, Litwin SE, Leon MB, Cutlip DE, Solomon SD, Starling RC, Cikes M, Borlaug BA, Kaye DM, Hasenfuß G, Shah SJ. Gyberg DJ, et al. Among authors: kaye dm. J Card Fail. 2025 Nov 29:S1071-9164(25)00436-1. doi: 10.1016/j.cardfail.2025.08.020. Online ahead of print. J Card Fail. 2025. PMID: 41325896 Review.

6

Non-invasive versus invasive estimation of left ventricular wall stress with cardiac magnetic resonance imaging in severe aortic stenosis.

Batchelor RJ, Papapostolou S, He J, Kearns J, Kaye DM, Stub D, Nanayakkara S, Walton A, Koshy AN, Taylor AJ. Batchelor RJ, et al. Among authors: kaye dm. J Cardiovasc Magn Reson. 2025 Nov 25;28(1):102016. doi: 10.1016/j.jocmr.2025.102016. Online ahead of print. J Cardiovasc Magn Reson. 2025. PMID: 41308996 Free PMC article.

7

Safety and performance of complex percutaneous coronary intervention in centres with and without on-site cardiac surgery: A multi-centre Australian study.

Dayawansa NH, Vogrin S, Zheng WC, Lefkovits J, Brennan AL, Dinh D, Reid CM, Stub D, Van Gaal W, Shaw JA, Chew DP, Clark D, Oqueli E, Kaye DM, Cox N, Peter K, Chan W. Dayawansa NH, et al. Among authors: kaye dm. Int J Cardiol. 2026 Feb 15;445:134032. doi: 10.1016/j.ijcard.2025.134032. Epub 2025 Nov 17. Int J Cardiol. 2026. PMID: 41260303

8

Ceramide as a Biomarker for HFpEF in Women: Menopause, Aging, and Pregnancy.

Magaye RR, Kaye DM, Wang BH. Magaye RR, et al. Among authors: kaye dm. Int J Mol Sci. 2025 Nov 6;26(21):10800. doi: 10.3390/ijms262110800. Int J Mol Sci. 2025. PMID: 41226834 Free PMC article. Review.

9

Effect of Empagliflozin on Whole Body, Cardiac, and Renal Sympathetic Outflows in Type 2 Diabetes.

Reutens AT, Lekamlage DH, Salim A, Shaw JE, Esler MD, Cooper ME, Kaye DM. Reutens AT, et al. Among authors: kaye dm. JACC Adv. 2025 Dec;4(12 Pt 2):102304. doi: 10.1016/j.jacadv.2025.102304. Epub 2025 Nov 8. JACC Adv. 2025. PMID: 41205543 Free PMC article.

10

Percutaneous Femoral Arterial Closure Following Decannulation of Venoarterial Extracorporeal Membrane Oxygenation Using the MANTA Vascular Closure Device.

Batchelor RJ, Diehl A, Vasudevan T, Nanayakkara S, Htun N, Pellegrino V, McGiffin D, Marasco S, Hodgson C, Kaye D, Stub D, Walton A. Batchelor RJ, et al. Among authors: kaye d. Heart Lung Circ. 2025 Dec;34(12):1409-1416. doi: 10.1016/j.hlc.2025.06.006. Epub 2025 Nov 1. Heart Lung Circ. 2025. PMID: 41176499

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,111 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,111 results

Results by year